Particular findings on lung CT in patients undergoing immunotherapy for bronchogenic carcinoma

BACKGROUND: Immune checkpoint inhibitors have become a valuable tool in the therapeutic strategy against metastasized non-small cell lung cancer (NSCLC) as they represent an effective and safe treatment option for many patients; however, the treatment response and side effects of this class of drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Beer, Lucian, Hochmair, Maximilian, Kifjak, Daria, Haug, Alexander R., Prayer, Florian, Mayerhoefer, Marius E., Herold, Christian, Prosch, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445205/
https://www.ncbi.nlm.nih.gov/pubmed/32430613
http://dx.doi.org/10.1007/s00508-020-01667-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445205/
https://www.ncbi.nlm.nih.gov/pubmed/32430613
http://dx.doi.org/10.1007/s00508-020-01667-0

Ejemplares similares